Nawrot Barbara, Sipa Katarzyna
Department of Bioorganic Chemistry, Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, 90-363 Lodz, Poland.
Curr Top Med Chem. 2006;6(9):913-25. doi: 10.2174/156802606777303658.
Short interfering RNAs (siRNAs) are 21-23 nt long double-stranded oligoribonucleotides which in mammalian cells exhibit a potency for sequence-specific gene silencing via an RNA interference (RNAi) pathway. It has been already proven that exogenous, chemically synthesized siRNA molecules are effective inhibitors of gene expression and are widely applied for analysis of protein function and proteomics-based target identification. Moreover, since their discovery siRNA molecules have been implemented as potential candidates for therapeutic applications. Variously modified siRNA molecules containing sugar modifications (2'-OMe, -F, -O-allyl, -amino, orthoesters and LNA analogues), internucleotide phospodiester bond modifications (phosphorothioates, boranophosphates), base modifications (s(2)U) as well as 3'-terminal cholesterol-conjugated constructs were investigated as potential candidates for effective inhibition of gene expression. This chapter reviews an impact of chemical and structural modifications of siRNA molecules on their serum and thermal stability, cellular and in vivo activity, cellular uptake, biodistribution and cytotoxicity. Functional analysis of chemically modified siRNA molecules allows for better understanding of the mechanism of the RNA interference process as well as demonstrates immense efforts in optimizing in vivo potency of siRNA molecules for RNAi-based drug design.
小干扰RNA(siRNA)是长度为21 - 23个核苷酸的双链寡核糖核苷酸,在哺乳动物细胞中,它通过RNA干扰(RNAi)途径表现出序列特异性基因沉默的能力。已经证明,外源化学合成的siRNA分子是基因表达的有效抑制剂,广泛应用于蛋白质功能分析和基于蛋白质组学的靶点鉴定。此外,自发现以来,siRNA分子已被用作治疗应用的潜在候选物。人们研究了各种修饰的siRNA分子,包括含有糖修饰(2'-O-甲基、氟、烯丙基、氨基、原酸酯和锁核酸类似物)、核苷酸间磷酸二酯键修饰(硫代磷酸酯、硼磷酸酯)、碱基修饰(2-硫代尿嘧啶)以及3'-末端胆固醇偶联构建体,作为有效抑制基因表达的潜在候选物。本章综述了siRNA分子的化学和结构修饰对其血清和热稳定性、细胞及体内活性、细胞摄取、生物分布和细胞毒性的影响。对化学修饰的siRNA分子进行功能分析,有助于更好地理解RNA干扰过程的机制,也展示了在优化siRNA分子的体内效力以用于基于RNAi的药物设计方面所做的巨大努力。